GENEVIEVE CASTANEDA: Open Payments
NPI 1386685808 · MONTVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$330 in 17 payments from 9 companies in 2025. Trend: 2023 $156 · 2024 $255 · 2025 $330
Food & beverage: $330
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 4 | $96 |
| Novo Nordisk Inc | 3 | $62 |
| PFIZER INC. | 3 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| Eisai Inc. | 1 | $19 |
| Invivyd Inc | 1 | $18 |
| Corcept Therapeutics | 1 | $18 |
| Amgen Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
Products named: Cologuard Collection Kit, Wegovy, CAPLYTA, NURTEC ODT, PREVNAR 20, Leqembi, PEMGARDA, Rybelsus.
Industry payments across NJ — which companies pay providers there.
